← Eichor
Study identifier: NCT06288373 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC

Condition: Cervical Cancer · Locally Advanced Cervical Cancer · Concurrent Chemoradiotherapy  ·  Sponsor: Tongji Hospital

PhasePhase 2/Phase 3
Planned participants440
Who can joinFemale, 18 Years to 70 Years
Healthy volunteersNo

About this study

It is a prospective, open-label, randomized, controlled phase II/III clinical trial in which patients with PD-L1-positive FIGO stage IB3, IIA2 and IIB(tumors \>4 cm in diameter)will be enrolled and randomly divided into the neoadjuvant chemoimmunotherapy plus surgery group and the CCRT group.

This description comes directly from the study's public registry record.

Talk to the study team

Kezhen Li  ·  086-027-8362  ·  tjkeke@126.com

Jing Chen  ·  086-027-8362  ·  chenjing3223@126.com

Always discuss trial participation with your own doctor first.

Locations (12)

Anhui Provincial Cancer HospitalHefei, Anhui, ChinaRecruiting
Beiing Friendship Hospital, Capital Medical UniversityBeijing, Beijing Municipality, ChinaRecruiting
The First Affiliated Hospital (Southwest Hospital), Army Medical University (Third Military Medical University)Chongqing, Chongqing Municipality, ChinaRecruiting
Gansu Provincial Maternity and Child-care HospitalLanzhou, Gansu, ChinaRecruiting
The Affiliated Tumor Hospital of Guangxi Medical UniversityNanning, Guangxi, ChinaRecruiting
Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyWuhan, Hubei, ChinaRecruiting
Xiangya Hospital, Central South UniversityChangsha, Hunan, ChinaRecruiting
Shengjing Hospital of China Medical UniversityShenyang, Liaoning, ChinaRecruiting
Second People's Hospital of Sichuan (Sichuan Cancer Hospital)Chengdu, Sichuan, ChinaRecruiting
Tianjin Medical University General HospitalTianjin, Tianjin Municipality, ChinaRecruiting
Women's Hospital, Zhejiang University School of MedicineHangzhou, Zhejiang, ChinaRecruiting
Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of SciencesHangzhou, Zhejiang, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06288373